Communities (formerly SIACs) and Scientific Working Groups (SWGs) are just two of many member benefits that DIA offers. Each Community provides a discipline-specific, global network where members can share common experiences and knowledge and connect with others in their particular field. Each SWG provides a cross-disciplinary group of professionals with relevant expertise to advance the science related to the medical product life cycle by addressing key issues and problems.
Communities Role in DIA. Communities provide a forum for volunteers to network and exchange information. Communities also assist DIA in identifying professional development needs in particular interest areas and in providing information to members in career and professional development, to meet those needs.
Community Leadership. Communities have a chairperson or co-chairpersons who take responsibility for the overall activities of the Community. A core committee facilitates the work of each Community.
Community Best Practices. “DIA Communities: Recommendations and Best Practices for a Successful Community” This document was developed by a subcommittee of the Community Leadership Council led by avid Clemow. It is intended to provide guidelines for building and operating successful DIA communities that meet the needs of their members and contribute to fulfillment of the DIA mission.
DIA ConneX. Community members automatically gain access to DIA ConneX, a trusted, interactive, web-based network that links DIA’s 18,000-member global community.
Already a DIA Member? Login to My DIA to join or manage your Communities and DIA ConneX.
Not a DIA Member? Join today.
Scientific Working Groups
Role in DIA. Scientific Working Groups provide a neutral forum for professionals from all settings, including industry, government, and academia, to share ideas and contribute knowledge and solutions that will advance the science of medical product development. The SWGs focus on creating innovative methods and tools and on promoting the dissemination of methods and best practices. They work with DIA through formats such as publications and educational events to share the outcomes of their efforts with all DIA members and the professional community at large.
SWG Leadership. SWGs have a chairperson or co-chairpersons who take responsibility for the overall activities of the SWG. A core committee or subteams may facilitate the work of the SWG.
Joining a SWG. The SWGs welcome professionals with relevant expertise and a commitment to contribute to the work of the group. Contact the SWG Chairperson or the Subteam Leader of the project that you wish to join for more information.
Scientific Working Groups include:
Adaptive Design SWG
Chair: Zoran Antonijevic, Cytel, Inc.: Zoran.Antonijevic@cytel.com
Bayesian Statistics SWG
Chair: Karen Price, Eli Lilly and Company: email@example.com
Comparative Effectiveness Research SWG
Chair: Matthew Rotelli, Eli Lilly and Company: firstname.lastname@example.org
Chair: Barbara Leishman, F. Hoffmann-La Roche Ltd.
Chemistry, Manufacturing & Controls/Quality System
Chair: Georges France, Novartis Consumer Health S.A.
Clinical Data Management
Chair: Peter Stokman, Merck Sharp and Dohme
Co-Chairs: Royce Morrison, RMD Insight, LLC and Stacie Bell, Mallinckrodt Pharmaceuticals and Howard Greenberg, Janssen R&D
Chair: Susan Nunchuck, Actelion Clinical Research
Clinical Safety & Pharmacovigilance
Chair: Scott McCulloch, TransPerfect Life Sciences
Clinical Trial Disclosure
Chair: Robert Paarlberg, Paarlberg & Associates LLC
Devices & Diagnostics
Chair: Shayesteh Fuerst-Ladani, SFL Regulatory Affairs and Scientific Communication
Document & Records Management
Chair: Lisa Mulcahy, Mulcahy Consulting, LLC
Electronic Information Integrity
Chair: Teri Stokes, GXP International
Electronic Regulatory Submissions
Chair: Adair Turner, Mission3, Inc.
Chair: Yasmin de Faria Krim, Janssen Pharmaceutical Companies of Johnson & Johnson
Ethics & the Medicines Lifecycle
Chair: Wendy Lipworth, University of Sydney
Evidence Based Medicine
Chair: Nimita Limaye, Tata Consultancy Services
Good Clinical Practices & Quality Assurance
Co-Chairs: Yvonne McCracken, Rx Trials Inc and Katharina Kurpanek, The QM Company
Chair: Pamela Campbell, EMC Corporation
Investigator & Investigative Sites
Chair: Ana Marquez, Marquez Clinical Site Partners, LLC
Chair: Marie Manley, Bristows LLP
Marketing & Sales
Chair: Stacey Fung, Genentech, A Member of the Roche Group
Medical Science Liaison
Chair: J. Lynn Bass, Jazz Pharmaceuticals
Chair: David Clemow, Lilly USA, LLC
Natural Health Products
Chair: Pradip Paul, Vertex Pharmaceuticals
Chair: Marcia Horn, International Cancer Advocacy Network (ICAN)
Chair: Gesine Bejeuhr, vfa Research-based Pharmaceutical Companies
Preclinical Sciences & OSWG
Co-Chairs: Joy Cavagnaro, Access BIO and David Schubert, Stealth Peptides
Professional Education, Training, & Development
Chair: Daniel Mudgett, Medidata Solutions Worldwide
Chair: John Sun, Novartis Pharmaceuticals Corporation
Quality Risk Management
Chair: Peter Schiemann, Widler & Schiemann Ltd
Chair: Linda Bowen, Sanofi US
Chair: Joan Buenconsejo, AstraZeneca Pharmaceuticals LP
Chair: Chad Gwaltney, ERT and Annabel Nixon, PRMA Consulting Ltd